Cargando…

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls

Detalles Bibliográficos
Autores principales:	Shah, Urvi A., Rögnvaldsson, Sæmundur, Derkach, Andriy, Björkholm, Magnus, Turesson, Ingemar, David, Yael, Hultcrantz, Malin, Tan, Carlyn, Hassoun, Hani, Korde, Neha, Lesokhin, Alexander, Mailankody, Sham, Kristinsson, Sigurður Yngvi, Landgren, C. Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719074/ https://www.ncbi.nlm.nih.gov/pubmed/34474548 http://dx.doi.org/10.3324/haematol.2021.278772

Ejemplares similares

Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2020)

History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
por: Lindqvist, Ebba K., et al.
Publicado: (2016)

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: THE MSKCC EXPERIENCE.
por: Firestone, Ross, et al.
Publicado: (2023)

Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma
por: Tan, Carlyn Rose, et al.
Publicado: (2023)

Fractures and survival in multiple myeloma: results from a population-based study
por: Thorsteinsdottir, Sigrun, et al.
Publicado: (2020)

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
por: Tan, Carlyn Rose, et al.
Publicado: (2023)

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends
por: Vélez, Ramón, et al.
Publicado: (2016)

Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
por: Goldin, Lynn R, et al.
Publicado: (2009)

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2023)

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
por: Hultcrantz, Malin, et al.
Publicado: (2020)

Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
por: Korde, Neha, et al.
Publicado: (2023)

P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION-BASED STUDY IN ICELAND AND SWEDEN
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Nutrition perceptions, needs and practices among patients with plasma cell disorders
por: Malik, Maria A., et al.
Publicado: (2022)

Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
por: Korde, Neha, et al.
Publicado: (2021)

P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MYELOMA MAY HAVE A LOWER RISK OF PROGRESSION COMPARED TO WHITE PATIENTS
por: Akhlaghi, T., et al.
Publicado: (2022)

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy
por: Hultcrantz, Malin, et al.
Publicado: (2015)

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
por: Hultcrantz, Malin, et al.
Publicado: (2020)

P894: INFECTION RISK BEFORE DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: RESULTS FROM THE SCREENED POPULATION-BASED ISTOPMM STUDY
por: Ros Levy, Marina, et al.
Publicado: (2023)

The half-painted picture: Reviewing the mental health impacts of cancer screening
por: Wadsworth, Lauren P., et al.
Publicado: (2022)

Run 368 P
por: Colchester, R J
Publicado: (1973)

Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis
por: Gadalla, Shahinaz M., et al.
Publicado: (2013)

Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease
por: Hofmann, Jonathan N, et al.
Publicado: (2017)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Rognvaldsson, Saemundur, et al.
Publicado: (2021)

Dietary intake is associated with risk of multiple myeloma and its precursor disease
por: Thordardottir, Marianna, et al.
Publicado: (2018)

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
por: Kazandjian, Dickran, et al.
Publicado: (2019)

3,6,8-Tribromoquinoline
por: Çelik, Ísmail, et al.
Publicado: (2010)

An Analysis of 368 Cases of Pulmonary Tuberculosis
Publicado: (1913)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

348. Etiology of Eosinophilic Meningitis in Korea
por: Park, Sunghee, et al.
Publicado: (2020)

Health Tract No. 348: Night Air
Publicado: (1868)

Test Run Report of the P348 Collaboration
por: Gninenko, S N
Publicado: (2015)

Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
por: Kim, Jongho, et al.
Publicado: (2013)

Correction to Lancet Psychiatry 2021; 8: 579–88
Publicado: (2021)

Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey
por: Landgren, O, et al.
Publicado: (2017)

348 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis
por: Zeher, Margit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u3v1e7b0m7h6ce0151q724ff1j